SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 2nd, 2024 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 31, 2024 (the “Effective Date”), between Alzamend Neuro, Inc., a Delaware corporation (the “Company”), and Ault Lending, LLC, a California limited liability company (the “Purchaser”).
ALZAMEND NEURO, INC. COMMON STOCK PURCHASE WARRANTAlzamend Neuro, Inc. • February 2nd, 2024 • Pharmaceutical preparations • New York
THIS CERTIFIES THAT, for value received, the Holder is entitled to purchase, and ALZAMEND NEURO, INC.., a Delaware corporation (the “Company”), promises and agrees to sell and issue to the Holder, at any time, or from time to time, during the Exercise Period, an aggregate of up to _____1 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), of the Company, at the Exercise Price, subject to the provisions and limitations and upon the terms and conditions hereinafter set forth. This Warrant is issued by the Company pursuant to that certain Securities Purchase Agreement dated as of January [ ], 2024 (the “Purchase Agreement”) pursuant to which the Company has offered and sold to the purchaser named therein shares of its Series A Preferred Stock (the “Preferred Shares”).
